Parkinson’s disease
Motor and non-motor outcomes, quality of life and safety are considered separately from laboratory markers.
Molecular hydrogen research by topic
Each topic is a collection of source-checked study records, not a treatment recommendation or a completed evidence synthesis.
Evidence boundaries remain visibleHuman studies are counted separately from animal and laboratory records. Biomarkers, symptoms, clinical events and other outcomes are not treated as interchangeable.
Metabolic and lipid health
Glucose regulation, lipid measures, clinical outcomes and safety are not treated as interchangeable.
Exercise and recovery
Performance, perceived fatigue, recovery measures and biological markers are reported as distinct outcomes.
Long COVID
Case definitions, symptom duration, function, quality of life and safety require study-specific interpretation.
Brain tumors — glioma and glioblastoma
Human reports and preclinical tumor models are separated; inclusion does not imply a treatment conclusion.
Cardiovascular and circulatory health
Clinical events, vascular function, symptoms and biomarkers are kept distinct.
Respiratory health
Symptoms, pulmonary function, clinical events and inflammation-related measures are considered separately.
Liver health
Human and preclinical findings, laboratory measures, imaging and clinical outcomes remain separate.
Cancer research
Cancer type, treatment setting and evidence stream matter; case reports and models are not clinical proof.
Gastrointestinal health
Symptoms, disease activity, function and microbiome-related measures are not treated as equivalent.
Kidney and urinary health
Kidney function, clinical events, symptoms, biomarkers and safety are reported by evidence stream.
Oral and dental health
Clinical, tissue, periodontal and healing outcomes are kept separate from surrogate measures.
Skin, wound and aging research
Healing, symptoms, objective skin measures and cosmetic outcomes require different interpretations.
Eye health
Vision-related function, symptoms and tissue outcomes are reported separately for human and preclinical research.
Musculoskeletal and pain research
Subjective symptoms, function, recovery, tissue outcomes and laboratory markers are kept distinct.
Immune and inflammatory conditions
A biomarker change is not automatically a clinical effect, and evidence streams remain separate.
Critical care and ischemia-reperfusion
Acute animal models are not presented as proof of benefit in patients.
Other neurological conditions
Distinct neurological conditions, clinical outcomes and biological measures are not combined without justification.
Sleep and mood research
Subjective scales, device-measured sleep, function and clinical outcomes remain distinct.
Women’s health
Questionnaire outcomes, biological markers, function and clinical events are reported separately.
Other molecular hydrogen research
This collection contains source-checked records that have not yet been assigned to a more specific public topic.